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Dear Editor,
We thank the authors for their interest in our paper [1],
although we have difficulty detecting their purpose.
However, they do provide us with an opportunity to
discuss and clarify anatomical issues as they affect experi-
mental methodology.
The letter opens with a declaration that “some questions
arise out of the described methodology.” Yet, we can find
little in the letter that pertains to our methods. Rather, the
letter appears to be a précis of a study conducted by the
authors that is tangentially related to our own study.
The authors offer a description of the dorsal sacral plexus,
but we are already familiar with this, and it is not germane
to the methodology, which is the stated concern of the
authors. Nor is the anatomy of the medial branches of the
sacral dorsal rami relevant to our study, which explicitly
addressed lateral branch blocks.
With respect to the technique that we used, the authors
raise the speculation ad hoc that injectate may have leaked
to the dorsal ramus itself. In the first instance, our previous
studies of sacral lateral branch blocks [2] found no evi-
dence of this phenomenon. In the second instance, spread
to the dorsal ramus makes no difference to the clinical
effect of the block. There is nothing that the dorsal ramus
does with respect to the sacroiliac joint that is not already
done by the lateral branches. The authors go on to state
that “this might account for the persistence of sensation of
sacroiliac joint capsular distension”; but the authors do not
explain how this might be so. They argue that “in such
cases the lateral branch blockade might be incomplete”;
but it cannot be incomplete if the dorsal ramus is blocked,
because the dorsal ramus contains the afferents contained
in the lateral branches.
The authors recount that we excluded certain patients
from our study. Their attempted criticism seems to imply
that we should have studied all comers. This contention
conflicts with opposing concerns. Had we complied with
the authors’ suggestion, others would have complained
that we included potentially confounding patients, who
had leakage of local anaesthetic to inappropriate sites. It is
a requirement for validation studies that the sample be
homogeneous, and free of confounding influences. In
other words, we are obliged to study the best cases in
order to get a clear answer to the question posed. The
virtue of our methods is that we used placebo-controls, in
a randomized sample. Under those conditions, the
“purity” of our subjects is equally distributed between the
samples, and with no confounding effects, only one ques-
tion is answered: did the active agent have an attributable
effect?
Otherwise, the comments about defects in the sacroiliac
joint and about tracking out of the joint to other sites are
immaterial to our study. Those phenomena might be rel-
evant to a study of intra-articular blocks, but they are not
relevant to our study, which explicitly focused on lateral
branch blocks.
Although we fail to see how the material raised by the
authors challenges or discredits our methodology and our
conclusions, we appreciate their interest and attention to
these important questions and our opportunity to discuss
them further.
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